In addition to anti-inflammatory action, GDF-15 was recently shown to participate cell signaling through glial cell-derived neurotrophic factor (GDNF) and family receptor a-like (GFRAL) and cause appetite suppression that may lead to cachexia, which is one of the aggravating factors in late stages of cancer [17,18,19]. The gene discussed is GDNF; the disease is cancer.